LOCUS       sequence-118386-         631 bp    DNA     linear   UNA 15-DEC-2025
DEFINITION  (control) when used to produce lentivirus, express physiological 
            levels of insert .
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      natural DNA sequence
  ORGANISM  unspecified
REFERENCE   1  (bases 1 to 631)
  AUTHORS   Martz CA, Ottina KA, Singleton KR, Jasper JS, Wardell SE, 
            Peraza-Penton A, Anderson GR, Winter PS, Wang T, Alley HM, Kwong LN,
            Cooper ZA, Tetzlaff M, Chen PL, Rathmell JC, Flaherty KT, Wargo JA, 
            McDonnell DP, Sabatini DM, Wood KC
  TITLE     Systematic identification of signaling pathways with potential to 
            confer anticancer drug resistance.
  JOURNAL   Sci Signal. 2014 Dec 23;7(357):ra121. doi: 
            10.1126/scisignal.aaa1877.
  PUBMED    25538079
REFERENCE   2  (bases 1 to 631)
  AUTHORS   .
  TITLE     Direct Submission
  JOURNAL   Exported Dec 15, 2025 from SnapGene Server 8.0.1
            https://www.snapgene.com
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "Sci 
            Signal."; date: "2014-12-23"; volume: "7(357):ra121. doi"; pages: " 
            10.1126/scisignal.aaa1877"
COMMENT     Sequence Label: HcRed-pcw107-V5
FEATURES             Location/Qualifiers
     source          1..631
                     /mol_type="genomic DNA"
                     /organism="unspecified"
     rep_origin      22..157
                     /label=SV40 ori
                     /note="SV40 origin of replication"
     polyA_signal    197..318
                     /label=SV40 poly(A) signal
                     /note="SV40 polyadenylation signal"
     primer_bind     complement(208..227)
                     /label=EBV-rev
                     /note="SV40 polyA terminator, reverse primer"
     primer_bind     262..281
                     /label=SV40pA-R
                     /note="SV40 polyA, reverse primer"
     LTR             396..629
                     /label=3' LTR (Delta-U3)
                     /note="self-inactivating 3' long terminal repeat (LTR) from
                     HIV-1"
ORIGIN
        1 gggcgattgg gtacgtccct aggcctccaa aaaagcctcc tcactacttc tggaatagct
       61 cagaggccga ggcggcctcg gcctctgcat aaataaaaaa aattagtcag ccatggggcg
      121 gagaatgggc ggaactgggc ggagttaggg gcgggatggg cggagttagg ggcgggatag
      181 ctagagccag acatgataag atacattgat gagtttggac aaaccacaac tagaatgcag
      241 tgaaaaaaat gctttatttg tgaaatttgt gatgctattg ctttatttgt aaccattata
      301 agctgcaata aacaagttcc tctcactctc tgatattcat ttctttgcaa gttataaata
      361 ctgaataata agatgacatg aactactata cgtactgcta gagattttcc acactgacta
      421 aaagggtctg agggatctct agttaccaga gtcacacaac agacgggcac acactacttg
      481 aagcactcaa ggcaagcttt attgaggctt aagcagtggg ttccctagtt agccagagag
      541 ctcccaggct cagatctggt ctaaccagag agacccagta caagcaaaaa gcagatcttg
      601 tcttcgttgg gagtgaatta gcccttccag t
//
